DMD and neuromuscular disease caused by qualitative or quantitative defects of dystrophin: In this study, three patients from two unrelated families were highly suspected of a sarcoglycanopathy or dystrophinopathy based on their clinical, muscle MRI, and pathological features, which drove us to perform muscle-derived mRNA studies of DMD and sarcoglycan genes after indefinite findings in routine genetic testing in them.